Literature DB >> 30768500

Choosing Wisely in Critical Care: Results of a National Survey From the Critical Care Societies Collaborative.

Ruth Kleinpell1,2, Curtis N Sessler3,4, Clareen Wiencek5,6, Marc Moss7,8.   

Abstract

OBJECTIVES: Over-utilization of tests, treatments, and procedures is common for hospitalized patients in ICU settings. American Board of Internal Medicine Foundation's Choosing Wisely campaign tasked professional societies to identify sources of overuse in specialty care practice. The purpose of this study was to assess how critical care clinicians were implementing the Critical Care Societies Collaborative Choosing Wisely recommendations in clinical practice.
DESIGN: Descriptive survey methodology with use of Research Electronic Data Capture (https://projectredcap.org/) sent via email newsletter blast or to individual emails of the 150,000 total members of the organizations.
SETTING: National survey.
SUBJECTS: ICU physicians, nurses, advanced practice providers including nurse practitioners and physician assistants, and pharmacist members of four national critical care societies in the United States.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A six-question survey assessed what Choosing Wisely recommendations had been implemented in ICU settings and if the impact was assessed. A total of 2,520 responses were received from clinicians: nurses (61%; n = 1538), physicians (25.9%; n = 647), advanced practice providers (10.5%; n = 263), and pharmacists (2.1%; n = 52), reflecting a 1.6% response rate of the total membership of 150,000 clinicians. Overall, 1,273 respondents (50.6%) reported they were familiar with the Choosing Wisely campaign. Respondents reported that Choosing Wisely recommendations had been integrated in a number of ways including being implemented in clinical care (n = 817; 72.9%), through development of a specific clinical protocol or institutional guideline (n = 736; 65.7%), through development of electronic medical record orders (n = 626; 55.8%), or with integration of longitudinal tracking using an electronic dashboard (n = 213; 19.0%). Some respondents identified that a specific quality improvement initiative was developed related to the Choosing Wisely recommendations (n = 468; 41.7%), or that a research initiative had been conducted (n = 156; 13.9%).
CONCLUSIONS: The results provide information on the application of the Choosing Wisely recommendations to clinical practice from a small sample of critical care clinicians. However, as only half of the respondents report implementation, additional strategies are needed to promote the Choosing Wisely recommendations to make impactful change to improve care in ICU settings.

Entities:  

Year:  2019        PMID: 30768500     DOI: 10.1097/CCM.0000000000003496

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Strategies to effect change in the ICU.

Authors:  David J Wallace
Journal:  Curr Opin Crit Care       Date:  2019-10       Impact factor: 3.687

2.  Mapping structure, process and outcomes in the removal of low-value care practices in Canadian intensive care units: protocol for a mixed-methods exploratory study.

Authors:  Jeanna Parsons Leigh; Jennie Petersen; Chloe de Grood; Liam Whalen-Browne; Daniel Niven; Henry Thomas Stelfox
Journal:  BMJ Open       Date:  2019-12-16       Impact factor: 2.692

3.  Shared decision-making for the treatment of proximal femoral fractures in frail institutionalised older patients: healthcare providers' perceived barriers and facilitators.

Authors:  Inge Spronk; Sverre A I Loggers; Pieter Joosse; Hanna C Willems; Romke Van Balen; Taco Gosens; Kornelis J Ponsen; Jeroen Steens; L C P Marc Van de Ree; Rutger G Zuurmond; Michael H J Verhofstad; Esther M M Van Lieshout; Suzanne Polinder
Journal:  Age Ageing       Date:  2022-08-02       Impact factor: 12.782

Review 4.  Choosing Wisely® in Hematology: Have We Made a Difference?

Authors:  Talal Hilal; Javier Munoz
Journal:  Curr Hematol Malig Rep       Date:  2020-08       Impact factor: 3.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.